Christin Gerhardt
Bern, BE 3012, Switzerland
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 21 publications
Ocular TGF-β, Matrix Metalloproteinases, and TIMP-1 Increase with the Development and Progression of Diabetic Retinopathy in Type 2 Diabetes Mellitus.
Journal: Mediators of inflammation
Published: April 29, 2021
Visual Outcome after Intravitreal Anti-VEGF Therapy for Macular Neovascularisation Secondary to Sorsby's Fundus Dystrophy: A Systematic Review.
Journal: Journal of clinical medicine
Published: April 22, 2021
Long-term outcomes of intravitreal therapy for symptomatic diabetic macular oedema in a real-world setting in Switzerland.
Journal: Graefe's archive for clinical and experimental ophthalmology = Albrecht von Graefes Archiv fur klinische und experimentelle Ophthalmologie
Published: December 20, 2020
Continued anti-VEGF treatment does not prevent recurrences in eyes with stable neovascular age-related macular degeneration using a treat-and-extend regimen: a retrospective case series.
Journal: Eye (London, England)
Published: September 03, 2020
Disease stability and extended dosing under anti-VEGF treatment of exudative age-related macular degeneration (AMD) - a meta-analysis.
Journal: Graefe's archive for clinical and experimental ophthalmology = Albrecht von Graefes Archiv fur klinische und experimentelle Ophthalmologie
Published: March 31, 2020
Risks and Challenges in Interpreting Simultaneous Analyses of Multiple Cytokines.
Journal: Translational vision science & technology
Published: December 17, 2019
Outcome of treatment for neovascular age-related macular degeneration by practice-based ophthalmologists compared with a macula clinic.
Journal: Graefe's archive for clinical and experimental ophthalmology = Albrecht von Graefes Archiv fur klinische und experimentelle Ophthalmologie
Published: November 07, 2019
Work and sleep quality in railway employees: an actigraphy study.
Journal: Ergonomics
Published: October 09, 2019
Adding a Corticosteroid or Switching to Another Anti-VEGF in Insufficiently Responsive Wet Age-Related Macular Degeneration.
Journal: Clinical ophthalmology (Auckland, N.Z.)
Published: July 24, 2019
Last Updated: 09/26/2026